The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human.
artemisinine results in increased activity of NR1I3 protein; artemisinine results in increased activity of NR1I3 protein alternative form; artemisinine results in increased activity of NR1I3 protein mutant form androstan-3-ol inhibits the reaction [artemisinine results in increased activity of NR1I3 protein mutant form]; artemisinine inhibits the reaction [androstan-3-ol results in decreased activity of NR1I3 protein alternative form]; artemisinine inhibits the reaction [Imidazoles results in decreased activity of NR1I3 protein alternative form]; Imidazoles inhibits the reaction [artemisinine results in increased activity of NR1I3 protein mutant form]